Mckesson Corp
NYSE:MCK
Relative Value
The Relative Value of one MCK stock under the Base Case scenario is 1 088.71 USD. Compared to the current market price of 518.81 USD, Mckesson Corp is Undervalued by 52%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
MCK Competitors Multiples
Mckesson Corp Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Mckesson Corp
NYSE:MCK
|
68B USD | 0.2 | 22.7 | 15.8 | 18.3 | ||
US |
Cencora Inc
NYSE:COR
|
47.3B USD | 0.2 | 25.3 | 13 | 18.3 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
25.9B USD | 0.1 | 40.5 | 9.1 | 12.2 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9B USD | 0.7 | 21.7 | 11.5 | 15.4 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
61.9B HKD | 0.1 | 6.4 | 1.5 | 1.8 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
54.8B CNY | 1.4 | 20.2 | 14.8 | 14.8 | ||
IT |
Amplifon SpA
MIL:AMP
|
7B EUR | 3.1 | 45.1 | 14.6 | 28.8 | ||
CN |
S
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
49.8B CNY | 0.2 | 13.2 | 7.9 | 7.9 | |
DE |
M
|
McKesson Europe AG
XHAM:CLS1
|
5B EUR | 0.2 | -5.1 | 3.9 | 19.2 |